← Back to Laurus Labs Ltd. overview
Laurus Labs Ltd. — 10-Year Financials
Annual P&L, balance sheet, and key ratios from public BSE/NSE filings.
| Period | Revenue | Net Profit | EPS (₹) | Total Assets | Shareholder Equity | ROE (%) | ROCE (%) | D/E | Net Margin (%) |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | ₹5,508 cr | ₹358 cr | ₹6.64 | ₹9,336 cr | ₹4,473 cr | 8.01% | 9.55% | 0.62x | 6.51% |
| FY2024 | ₹5,002 cr | ₹161 cr | ₹2.97 | ₹8,387 cr | ₹4,111 cr | 3.91% | 6.1% | 0.63x | 3.21% |
| FY2023 | ₹6,014 cr | ₹790 cr | ₹14.64 | ₹7,660 cr | ₹4,038 cr | 19.57% | 20.35% | 0.5x | 13.14% |
| FY2022 | ₹4,889 cr | ₹828 cr | ₹15.35 | ₹6,968 cr | ₹3,351 cr | 24.69% | 22.61% | 0.53x | 16.93% |
Revenue: Total income from operations (₹ crore).
EPS: Earnings per share (₹), basic.
ROE: Net profit / average shareholder equity.
ROCE: EBIT / capital employed.
D/E: Total debt / shareholder equity.
Net Margin: Net profit as a % of revenue.
All figures sourced from public BSE/NSE filings. Ratios are pre-computed estimates and may differ from primary filings due to rounding.
Educational content — not investment adviceAll financial data is sourced from public filings and shown here for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing on this page constitutes a recommendation or solicitation to transact in any security. All data is at least 90 days old. Past performance is not indicative of future results.